Search
for

    Sort by

    Research 721–750 of 1000+

    1. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    2. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation Annals of Translational Medicine · 2021 · 4 citations
    3. Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem) Reports of Practical Oncology & Radiotherapy · 2020 · 4 citations
    4. Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels PloS one · 2018 · 4 citations
    5. Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment 2015 · 4 citations
    6. Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate? BJUI · 2002 · 4 citations
    7. Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway Frontiers in Pharmacology · 2024 · 3 citations
    8. Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men American Journal of Men s Health · 2023 · 3 citations
    9. Relative search popularity of five advanced prostate cancer medications using Google Trends Prostate Cancer and Prostatic Diseases · 2023 · 3 citations
    10. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis BMC Cancer · 2018 · 3 citations
    11. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    12. Potential roles of FGF5 as a candidate therapeutic target in prostate cancer. PubMed · 2023 · 2 citations
    13. High-throughput and direct measurement of androgen levels using turbulent flow chromatography liquid chromatography-triple quadrupole mass spectrometry (TFC-LC-TQMS) to discover chemicals that modulate dihydrotestosterone production in human prostate cancer cells Biotechnology Letters · 2017 · 2 citations
    14. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    15. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I Mayo Clinic Proceedings · 2006 · 2 citations
    16. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    17. Terapia antiandrogénica como quimioprevención del cáncer de próstata Medicina de Familia SEMERGEN · 2004 · 1 citations
    18. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations
    19. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    20. 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times? Cancer Epidemiology, Biomarkers & Prevention · 2022 · 1 citations
    21. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 1 citations
    22. Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia Egyptian Journal of Dermatology and Venereology · 2020 · 1 citations
    23. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. PubMed · 2019 · 1 citations
    24. Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome Mağallaẗ Kulliyyaẗ al-ṭibb Baġdād · 2016 · 1 citations
    25. Prostate-specific antigen as a diagnostic marker in female hyperandrogenism Journal of the Egyptian Women's Dermatologic Society (Print) · 2013 · 1 citations
    26. <i>Arachis hypogaea</i> L. Root Extract Mitigates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone Food Science & Nutrition · 2026
    27. Spermatogenic and Androgenic Potential of Nephrolepis biserrata on Testosterone- Propionate Induced Benign Prostatic Hyperplasia In Male Wistar Rats Journal of Applied Health Sciences and Medicine · 2024
    28. Alopecia androgénica como factor predictor de hiperplasia benigna de próstata Universidad Privada Antenor Orrego · 2018
    29. Efecto del extracto hidroetanólico de semillas de Coffea arabica L. sobre la hiperplasia prostática inducida en Mus musculus var. swiss orquiectomizados Universidad Nacional de Trujillo · 2017
    30. Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved] Faculty of 1000 Research Ltd · 2015